HomeCompaniesCuraleaf International
Company
Curaleaf International
TSX: CURA
London-headquartered European and Australasian arm of Curaleaf Holdings, Inc. (TSX: CURA; OTCQX: CURLF), the vertically integrated medical-cannabis group. Cultivates, processes and distributes cannabis-derived medicines across the UK, EU, Australia and New Zealand.
1 story
Regulatory News has published 1 story about Curaleaf International on 6 October 2026, sourced to the primary record — the regulator’s decision, the company’s filing or its own announcement. This page is generated from that coverage. Last updated 6 October 2026.
This page is generated from Regulatory News’ editorial coverage of Curaleaf International. It is not an advertisement.
On the record
- Company
- Curaleaf International (Curaleaf Holdings, Inc.)
- Headquarters
- London, United Kingdom (Curaleaf International); parent Curaleaf Holdings headquartered in Wakefield, Massachusetts
- Founded
- 2018 (Curaleaf International); parent Curaleaf Holdings founded 2010 by Boris Jordan and Cameron Forni
- Regulator
- Therapeutic Goods Administration (TGA), Australia; Medsafe, New Zealand
Each line is taken from the most recent story of ours that states it.
Products in our coverage
Our coverage
